Furthermore, the authors reported that inflammatory bowel disease and experimental colitis were associated with a reduction in the expression of GDNF and that restoring GDNF was sufficient to inhibit the inflammation-induced compromise in the epithelial barrier both in vivo and in vitro (34). This evidence concerns the gene GDNF and inflammatory bowel disease.